There was a huge amount of groundbreaking research and news to choose from. So I have grouped my choices into categories, rather than a standard top ten list. These are my choices, including the ones I think are the most exciting, the hottest topics, or the most thought provoking.
New drugs in development
- In August, Pipex Pharmaceuticals, Inc. acquired dnaJP1, an oral, once-daily RA medication that is currently in clinical trials. DnaJP1 is a biologic drug, like Humira and Remicade...
